期刊文献+

人脐血树突状细胞体外扩增的研究 被引量:2

Generation of dendritic cells from human cord blood
下载PDF
导出
摘要 目的 探讨人脐血来源的树突状细胞 (dendriticcells,DC )的体外培养、增殖情况。方法 采用密度梯度离心法获得界面细胞 ,贴壁培养 2小时 ,获得单个核细胞 ,体外以重组hGM CSF(5 0ng ml) +hIL 4 (10ng ml) +hTNF α(5 0ng ml)诱导培养 2周。在DC发育过程中 ,在光镜下观察其生长情况 ,流式细胞仪检测DC表型。结果 体外培养的DC在第四天由贴壁状态变为悬浮毛刺状细胞 ,随着培养时间的延长 ,此类细胞数量增多 ,第八天为形态不规则的毛刺状 ,为典型树突状细胞形态。流式细胞仪显示体外培养成熟的DC高表达共刺激分子CD80、黏附分子CD5 4、MHCII类分子HLA DR。结论 人脐血经hGM CSF +hIL 4 +hTNF α体外培养 ,能诱导出DC ,本研究为DC的深入研究与临床应用奠定了基础。 Objective: To investigate the culture and proliferation of dendritic cells derived from cord blood in vitro. Methods: The mononuclear cells were prepared from cord blood with Ficoll-hypaque centrifugation method, then induced with the recombinant cytokines hGM-CSF(50 ng/ml) ,hIL-4(10 ng/ml) and hTNF-α(50 ng/ml)for two weeks. We observed the DCs growth and determined DCs phenotypes by flow cytometry. Results: The dendritic cells culturedin vitro turned into suspensive growth from adhesive situation at 4d, along with the incubation, the number of DCs increased and the cells showed the irregular morphologic appearance of DCs with veiled edges in the 8th day. The mature DCs could express the relatively specific marker such as co-stimulatory molecules CD80, adhesion molecule CD54 and MHC-Ⅱmolecule HLA-DR. Conclusion: The dendritic cells can be induced from human cord blood that is co-incubated with hGM-CSF, hIL-4 and hTNF-α in vitro. The investigation establishes a foundation for furthur research and clinical use of DCs.
出处 《泰山医学院学报》 CAS 2003年第2期127-129,共3页 Journal of Taishan Medical College
基金 泰安市科技局基金资助项目 (No2 0 0 1)
关键词 树突状细胞 脐血 粒细胞-巨噬细胞集落刺激因子 白细胞介素-4 肿瘤坏死因子Α dendritic cells cord blood granulocyte-macrophage colony-stimulating factor interleukin-4 tumor necrosis factorα
  • 相关文献

参考文献9

  • 1宋文刚,于益芝,曲迅,刘书逊,王闻雅,张明徽,唐玲,厉永建,曹雪涛.肿瘤细胞培养上清对小鼠骨髓来源的树突状细胞分化发育的影响[J].中国肿瘤生物治疗杂志,2001,8(2):134-134. 被引量:14
  • 2朱学军,曹雪涛,于益芝,陈国友,万涛,马施华,唐华,章卫平.人外周血树突状细胞的体外扩增及鉴定[J].中国肿瘤生物治疗杂志,1997,4(4):302-306. 被引量:91
  • 3Romani N, Gruner S, Brang D, et al. Proliferating dendritic cell progenitors in human blood[J]. J Exp Med, 1994, 180:83-93.
  • 4Tarte K, Klein B. Dendritic cell-based vaccine: a promising approach for cancer immunotherapy[J]. Leukemia, 1999, 13(5):653-663.
  • 5Lutz MB, Kukutsch N, Ogilvie AL, et al. An advanced culture method for generation large quantities of highly pure dendritic cells from mouse bone marrow[J]. J Immunol Methods, 1999,223:77-92.
  • 6Banchereau J, Steinman RM. Dendritic cells and the control of immunity[J]. Nature, 1998, 392(6673) :245-252.
  • 7Herbst B, Kohler G, Mackensen A, et al. CD34^+ peripheral blood progenitor cell and monocyte derived dendritic cells: a comparative analysis[J]. Br J Haematol, 1997,99:490-499.
  • 8Strobl H, Riedl E, Scheinecker C, et al. TGF-beta 1 promotes in vitro development of dendritic cells from CD34^+ hemopoietic progenitors[J]. J Immunol, 1996, 157:1499-1507.
  • 9Morse MA, Coleman RE, Akabani G, Niehaus N, Coleman D,Lyerly HK.Migration of human dendritic cells after injection in patients with metastatic malignancies[J ]. Cancer Res, 1999, 59:56-58.

二级参考文献10

  • 1[1]Steinman, RM. The dendritic cell system and its role in immunogenicity [J]. Annu Rev Immunol, 1991, 9: 271-296.
  • 2[2]Restifo NP. Not so FAS: Re-evaluating the mechanisms of immune privilege and tumor escape [J]. Nat Med, 2000, 6(5): 493-495.
  • 3[3]Heufler C, Koch F, Stanzl U, et al. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-γ production by T helper 1 cells [J]. Eur J Immunol, 1996, 26(3): 659-668.
  • 4[4]Cao X, Zhang W, Wang J, et al. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells [J]. Immunology, 1999, 97(7): 616-625.
  • 5[5]Van Gool SW, de Boer M, Ceuppens JL. The combination of anti-B7 monoclonal antibody and cyclosporin a induces alloantigen-specific anergy during a primary mix lymphocytes reaction [J]. J Exp Med, 1994, 179(2): 715-720.
  • 6[6]Judge TA, Tang A, Turka LA. Immunosuppression through blockade of CD28:B7-mediated costimulatory signals [J]. Immunol Res, 1996, 5(1): 38-49.
  • 7[7]Lamont AG, Adorini L. IL-12, a key cytokine in immune regulation [J]. Immunol Today, 1996, 17(5): 214-217.
  • 8[8]Shu U, Kiniwa M, Wu CY, et al. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction [J]. Eur J Immunol, 1995, 25(4): 1125-1128.
  • 9[9]Maeda H, Takata M, Takahashi S, et al. Adoptive transfer of a Th2-like cell line prolongs MHC class II antigen disparate skin allograft survival in the mouse [J]. Int Immunol, 1994, 6(6): 855-862.
  • 10[10]Sayegh M H, Akalin E, Hancock WW, et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spare Th2 [J]. J Exp Med, 1995, 181(5): 1869-1874.

共引文献100

同被引文献14

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部